Healthpeak Q2 2026 Lab Leasing Shows Stable Rates and Rising Mid-Sized Demand
Healthpeak’s Q2 2026 review shows a lab leasing market characterized by stable rates that align with the portfolio, modest use-dependent concessions, and generally low capex for second-generation occupancy. The mix is shifting toward 25k–75k sq ft spaces as financing improves, with wet-lab biotech demand concentrated in core assets.
Read post